CSF1R and neoplasm: Blockade of CSF1R using small-molecule inhibitors, such as BLZ945, has shown efficacy in glioma, where treatment led to TAMs with increased expression of antigen presentation genes (146) and downregulation of pro-tumour macrophage markers (147).